Portfolio (Quarterly)
Guide ↗
Virtus Investment Advisers, LLC
· CIK 0000019481| # | Ticker | Company | Sector | Shares | Value ↓ | % Port | Chg Shares | Chg % | Period Price ① | Since Period ① |
|---|---|---|---|---|---|---|---|---|---|---|
| 261 | TPVG | TRIPLEPOINT VENTURE GROWTH B | Financial Services | 68,513.0 | $342K | 0.09% | -1K | -1.5% | $4.99 | +16.8% |
| 262 | RLAY | RELAY THERAPEUTICS INC | Healthcare | 33,957.0 | $338K | 0.09% | +827.0 | +2.5% | $9.95 | +21.6% |
| 263 | ANAB | ANAPTYSBIO INC | Healthcare | 6,067.0 | $336K | 0.09% | +148.0 | +2.5% | $55.46 | +5.9% |
| 264 | RVMD | REVOLUTION MEDICINES INC | Healthcare | 3,454.0 | $336K | 0.09% | +83.0 | +2.5% | $97.25 | +48.5% |
| 265 | OFS | OFS CAP CORP | Financial Services | 92,665.0 | $329K | 0.09% | +10K | +12.7% | $3.55 | -4.1% |
| 266 | — | PRAXIS PRECISION MEDICINES I | — | 1,013.0 | $326K | 0.09% | +24.0 | +2.4% | $322.19 | — |
| 267 | CGEM | CULLINAN THERAPEUTICS INC | Healthcare | 22,875.0 | $325K | 0.09% | +557.0 | +2.5% | $14.21 | +4.6% |
| 268 | TERN | TERNS PHARMACEUTICALS INC | Healthcare | 6,058.0 | $319K | 0.09% | +146.0 | +2.5% | $52.72 | +0.4% |
| 269 | PHVS | PHARVARIS N V | Healthcare | 11,286.0 | $319K | 0.09% | +275.0 | +2.5% | $28.25 | +1.8% |
| 270 | CAPR | CAPRICOR THERAPEUTICS INC | Healthcare | 10,479.0 | $319K | 0.09% | +255.0 | +2.5% | $30.40 | -7.8% |
| 271 | CLDX | CELLDEX THERAPEUTICS INC NEW | Healthcare | 9,911.0 | $314K | 0.09% | +240.0 | +2.5% | $31.72 | -4.7% |
| 272 | LQDA | LIQUIDIA CORPORATION | Healthcare | 8,169.0 | $308K | 0.09% | +200.0 | +2.5% | $37.74 | +51.0% |
| 273 | BLTE | BELITE BIO INC | Healthcare | 1,929.0 | $308K | 0.09% | +47.0 | +2.5% | $159.44 | -10.4% |
| 274 | CTMX | CYTOMX THERAPEUTICS INC. | Healthcare | 65,080.0 | $306K | 0.08% | +2K | +2.5% | $4.70 | -25.4% |
| 275 | IMNM | IMMUNOME INC | Healthcare | 13,932.0 | $305K | 0.08% | +339.0 | +2.5% | $21.87 | -9.0% |
| 276 | ANNX | ANNEXON INC | Healthcare | 54,866.0 | $304K | 0.08% | +1K | +2.5% | $5.54 | -9.5% |
| 277 | PTGX | PROTAGONIST THERAPEUTICS INC | Healthcare | 2,860.0 | $301K | 0.08% | +70.0 | +2.5% | $105.40 | -4.4% |
| 278 | — | APOGEE THERAPEUTICS INC | — | 3,538.0 | $298K | 0.08% | +87.0 | +2.5% | $84.17 | — |
| 279 | CELC | CELCUITY INC | Healthcare | 2,589.0 | $296K | 0.08% | +61.0 | +2.4% | $114.14 | +15.8% |
| 280 | SMMT | SUMMIT THERAPEUTICS INC | Healthcare | 15,519.0 | $294K | 0.08% | +378.0 | +2.5% | $18.96 | -15.5% |
① Period Price is the implied market price on the last day of the reporting period, calculated as reported value ÷ shares held. It is not the fund's purchase price or cost basis — the fund may have initiated or added to the position at any point during the quarter at a different price. Since Period shows the price change from that quarter-end snapshot to today's last price — it reflects stock movement after the report date, not the fund's actual return.
Sector Allocation
Healthcare
30.6%
Financial Services
23.4%
Industrials
11.2%
Technology
10.7%
Consumer Cyclical
7.6%
Energy
3.4%
Basic Materials
3.4%
Communication Services
3.1%
Consumer Defensive
2.9%
Real Estate
2.2%